Spatz FGIA

Great Neck, United States Founded: 2005 • Age: 21 yrs
Minimally invasive gastric balloon is developed for obesity satiety induction.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 7 Brand Intelligence

About Spatz FGIA

Spatz FGIA is a company based in Great Neck (United States) founded in 2005 by Jeffrey Brooks. Spatz FGIA offers products and services including Spatz3 Adjustable Gastric Balloon. Spatz FGIA operates in a competitive market with competitors including Allurion, Apollo Endo, Sedivention, GT Metabolic Solutions and IG Balloon, among others.

  • Headquarter Great Neck, United States
  • Founders Jeffrey Brooks
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Spatz Fgia Inc
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Spatz FGIA

Spatz FGIA offers a comprehensive portfolio of products and services, including Spatz3 Adjustable Gastric Balloon.

Product name locked
Category locked
Primary

Non-invasive tool to assist weight loss by inducing satiety.

Funding Insights of Spatz FGIA

Premium access

Detailed funding history for Spatz FGIA

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Spatz FGIA

Investments
Premium access

Investment portfolio details for Spatz FGIA

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Spatz FGIA

Premium access

Detailed financials for Spatz FGIA

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Spatz Fgia Comparisons

Spatz FGIA Primary company
Description
Minimally invasive gastric balloon is developed for obesity ...
Location
Great Neck, United States
Founded Year
2005
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Spatz FGIA

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Spatz FGIA

Spatz FGIA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Allurion, Apollo Endo, Sedivention, GT Metabolic Solutions and IG Balloon, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
Locked Locked Locked
Therapeutic devices for obesity and GI disorders are developed.
Locked Locked Locked
Developer of a minimally invasive cryo-ablation therapy for obesity. This outpatient procedure uses cryo-ablation technology to disrupt the gastric branches of the vagus nerve, permanently reducing hunger feelings. A medical device has been developed and successfully tested for safety and efficacy. The therapy aims to provide a long-term solution for weight loss, addressing a significant unmet medical need. The company is supported by several awards and investments.
Locked Locked Locked
Incision-less bariatric surgery technology is developed for gastric bypass.
Locked Locked Locked
Offers updates on medical device designs and clinical trial outcomes.
Premium access

Detailed competitors of Spatz FGIA

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Spatz Fgia

Premium access

Complete news archive for Spatz FGIA

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Spatz FGIA

Spatz FGIA was founded in 2005.

Spatz FGIA is headquartered in Great Neck, United States. It is registered at Great Neck, New York, United States.

Jeffrey Brooks is the current CEO of Spatz FGIA. They have also founded this company.

Spatz FGIA is developing a minimally invasive device for obesity. The companys flagship product, the Spatz Adjustable Balloon System is a medical grade, saline-filled gastric balloon with attached anchor and adjustability valve that rests in the stomach cavity and decreases appetite by occupying approximately a third of the stomach volume. In addition, with the gastric balloon in place, the stomach empties more slowly, keeping you feeling full longer. It is implanted endoscopically in an outpatient procedure and works by reducing stomach capacity to give a feeling of satiety. The adjustability valve allows the volume of the balloon to be changed as per patient needs. The balloon is designed to stay in the stomach for upto 1 year before it requires removal. The product received the CE mark in 2010 and is sold across 30 countries. The product is not approved by FDA for use within the US.

Spatz FGIA's top competitors include Allurion, Apollo Endo and GT Metabolic Solutions.

Spatz FGIA offers Spatz3 Adjustable Gastric Balloon.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available